Atlas Trials

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN

Clinical trial NCT06735560 · RECRUITING

Trial details

NCT number
NCT06735560
Sponsor
Nantes University Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Neuroendocrine Tumors
Start date
2025-11-04
Primary completion
2027-05-04
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.